210 related articles for article (PubMed ID: 26125969)
1. Total Synthesis of the Glycosylated Macrolide Antibiotic Fidaxomicin.
Kaufmann E; Hattori H; Miyatake-Ondozabal H; Gademann K
Org Lett; 2015 Jul; 17(14):3514-7. PubMed ID: 26125969
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis of the tiacumicin B (lipiarmycin A3/fidaxomicin) aglycone.
Glaus F; Altmann KH
Angew Chem Int Ed Engl; 2015 Feb; 54(6):1937-40. PubMed ID: 25510439
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of the protected aglycon of fidaxomicin (tiacumicin B, lipiarmycin A3).
Miyatake-Ondozabal H; Kaufmann E; Gademann K
Angew Chem Int Ed Engl; 2015 Feb; 54(6):1933-6. PubMed ID: 25431322
[TBL] [Abstract][Full Text] [Related]
4. Total Synthesis of Tiacumicin A. Total Synthesis, Relay Synthesis, and Degradation Studies of Fidaxomicin (Tiacumicin B, Lipiarmycin A3).
Hattori H; Kaufmann E; Miyatake-Ondozabal H; Berg R; Gademann K
J Org Chem; 2018 Jul; 83(13):7180-7205. PubMed ID: 29590752
[TBL] [Abstract][Full Text] [Related]
5. Fidaxomicin for the treatment of Clostridium difficile infections.
Whitman CB; Czosnowski QA
Ann Pharmacother; 2012 Feb; 46(2):219-28. PubMed ID: 22318930
[TBL] [Abstract][Full Text] [Related]
6. Fidaxomicin: a macrocyclic antibiotic for the management of Clostridium difficile infection.
Sullivan KM; Spooner LM
Ann Pharmacother; 2010 Feb; 44(2):352-9. PubMed ID: 20071495
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective synthesis of putative lipiarmycin aglycon related to fidaxomicin/tiacumicin B.
Erb W; Grassot JM; Linder D; Neuville L; Zhu J
Angew Chem Int Ed Engl; 2015 Feb; 54(6):1929-32. PubMed ID: 25422174
[TBL] [Abstract][Full Text] [Related]
8. Fidaxomicin, a new treatment for Clostridium difficile infections.
Epstein L; Golan Y
Drugs Today (Barc); 2012 Feb; 48(2):101-8. PubMed ID: 22384450
[TBL] [Abstract][Full Text] [Related]
9. Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment of Clostridium difficile infections.
Soriano MM; Liao S; Danziger LH
Expert Rev Anti Infect Ther; 2013 Aug; 11(8):767-76. PubMed ID: 23977933
[TBL] [Abstract][Full Text] [Related]
10. Fidaxomicin: a novel macrolide antibiotic for Clostridium difficile infection.
Chahine EB; Sucher AJ; Mantei K
Consult Pharm; 2014 Sep; 29(9):614-24. PubMed ID: 25203410
[TBL] [Abstract][Full Text] [Related]
11. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections.
Lancaster JW; Matthews SJ
Clin Ther; 2012 Jan; 34(1):1-13. PubMed ID: 22284993
[TBL] [Abstract][Full Text] [Related]
12. Total Synthesis of Tiacumicin B: Implementing Hydrogen Bond Directed Acceptor Delivery for Highly Selective β-Glycosylations.
Norsikian S; Tresse C; François-Eude M; Jeanne-Julien L; Masson G; Servajean V; Genta-Jouve G; Beau JM; Roulland E
Angew Chem Int Ed Engl; 2020 Apr; 59(16):6612-6616. PubMed ID: 32003915
[TBL] [Abstract][Full Text] [Related]
13. Fewer recurrent infections of C. difficile seen with fidaxomicin. This new class of antibiotic--the macrocycles--has a greater sustained response against re-infection than vancomycin.
Morrow T
Manag Care; 2011 Jul; 20(7):49-50. PubMed ID: 21848202
[No Abstract] [Full Text] [Related]
14. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
[TBL] [Abstract][Full Text] [Related]
15. Fidaxomicin: first-in-class macrocyclic antibiotic.
Mullane KM; Gorbach S
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):767-77. PubMed ID: 21810048
[TBL] [Abstract][Full Text] [Related]
16. Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection.
Hardesty JS; Juang P
Pharmacotherapy; 2011 Sep; 31(9):877-86. PubMed ID: 21923589
[TBL] [Abstract][Full Text] [Related]
17. A convergent ring-closing metathesis approach to carbohydrate-based macrolides with potential antibiotic activity.
Blom P; Ruttens B; Van Hoof S; Hubrecht I; Van der Eycken J; Sas B; Van hemel J; Vandenkerckhove J
J Org Chem; 2005 Nov; 70(24):10109-12. PubMed ID: 16292849
[TBL] [Abstract][Full Text] [Related]
18. Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis.
Hostler CJ; Chen LF
Expert Opin Pharmacother; 2013 Aug; 14(11):1529-36. PubMed ID: 23683070
[TBL] [Abstract][Full Text] [Related]
19. Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection.
Venugopal AA; Johnson S
Clin Infect Dis; 2012 Feb; 54(4):568-74. PubMed ID: 22156854
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?
Cornely OA
Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():28-35. PubMed ID: 23121552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
